UPDATE: Deutsche Bank Raises PT on Abbott Laboratories on 1Q13 Earnings Preview
April 12, 2013 at 10:41 AM EDT
In a report published Friday, Deutsche Bank analyst Kristen Stewart reiterated a Hold rating on Abbott Laboratories (NYSE: ABT ), and raised the price target from $33.00 to $35.00. In the report, Stewart noted, “The focus remains on utilization and pricing trends across the sector. Keep in mind, some companies
